Form 8-K FIVE PRIME THERAPEUTICS For: Nov 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Oil slips as Saudi Arabia offers more crude via Oman
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- Bernstein on Crypto: 'Clarity fails - what next?'
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Five Prime Therapeutics (FPRX) Tops Q3 EPS by 6c
November 4, 2015 5:01 PM ESTFive Prime Therapeutics (NASDAQ: FPRX) reported Q3 EPS of ($0.93), $0.06 better than the analyst estimate of ($0.99). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $4.9 million.
For earnings history and earnings-related data on Five Prime Therapeutics (FPRX) click here.
... More